Diag’nCell was created following close collaboration between clinicians and researchers working to propose novel approaches for patient care. Based in both Lyon and Montpellier, France, the company’s expert team aims to leverage their research capacity to develop new genetic tests. To complement this approach, Diag’nCell also performs functional characterization of genetic variations identified in patients.
Every single patient suffering from a hereditary cardiac disease is entitled to benefit from relevant diagnosis and the appropriate associated treatment.
WHAT WE DO ?
Diag’nCell uses today’s most advanced technologies to develop diagnostic services for hereditary diseases to assist clinicians in their daily practice.